APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Imaging and Diagnostics System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Imaging and Diagnostics System Market Outlook and Growth Opportunities 2026

8 January 2026198 pages

Choose your research edition.

Industry ResearchAI Imaging and Diagnostics System Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Imaging and Diagnostics System Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal AI Imaging and Diagnostics System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Imaging and Diagnostics System Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Imaging and Diagnostics System Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global AI Imaging and Diagnostics System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Imaging and Diagnostics System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Imaging and Diagnostics System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Imaging and Diagnostics System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Imaging and Diagnostics System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Imaging and Diagnostics System market include Siemens Healthineers AG, GE Healthcare, IBM Watson Health, Philips Healthcare, AliveCor Inc., Zebra Medical Vision, Inc., Riverain Technologies, Vuno, Inc. and Aidoc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Imaging and Diagnostics System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Imaging and Diagnostics System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Imaging and Diagnostics System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Imaging and Diagnostics System market.

AI Imaging and Diagnostics System Segment by Company

Siemens Healthineers AG

GE Healthcare

IBM Watson Health

Philips Healthcare

AliveCor Inc.

Zebra Medical Vision, Inc.

Riverain Technologies

Vuno, Inc.

Aidoc

Neural Analytics

Imagen Technologies

Digital Diagnostics, Inc.

Google (Subsidiary of Alphabet, Inc.)

Heartflow

Digital Diagnostics (Formerly Known as Idx)

AI Imaging and Diagnostics System Segment by Type

Hardware

Software

AI Imaging and Diagnostics System Segment by Application

Hospitals

Diagnostic Centers

Others

AI Imaging and Diagnostics System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Imaging and Diagnostics System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Imaging and Diagnostics System key companies, revenue, market share, and recent developments.

3. To split the AI Imaging and Diagnostics System breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Imaging and Diagnostics System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Imaging and Diagnostics System significant trends, drivers, influence factors in global and regions.

6. To analyze AI Imaging and Diagnostics System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Imaging and Diagnostics System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Imaging and Diagnostics System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Imaging and Diagnostics System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Imaging and Diagnostics System industry.

Chapter 3: Detailed analysis of AI Imaging and Diagnostics System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Imaging and Diagnostics System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Imaging and Diagnostics System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Imaging and Diagnostics System Industry Trends Table 2. AI Imaging and Diagnostics System Industry Drivers Table 3. AI Imaging and Diagnostics System Industry Opportunities and Challenges Table 4. AI Imaging and Diagnostics System Industry Restraints Table 5. Global AI Imaging and Diagnostics System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Imaging and Diagnostics System Revenue Share by Company (2021-2026) Table 7. Global AI Imaging and Diagnostics System Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Imaging and Diagnostics System Key Company Manufacturing Base & Headquarters Table 9. Global AI Imaging and Diagnostics System Company, Product Type & Application Table 10. Global AI Imaging and Diagnostics System Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Imaging and Diagnostics System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hardware Table 15. Significant Companies of Software Table 16. Global AI Imaging and Diagnostics System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI Imaging and Diagnostics System Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI Imaging and Diagnostics System Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI Imaging and Diagnostics System Sales Value Share by Type (2021-2026) Table 20. Global AI Imaging and Diagnostics System Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Diagnostic Centers Table 23. Significant Companies of Others Table 24. Global AI Imaging and Diagnostics System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global AI Imaging and Diagnostics System Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global AI Imaging and Diagnostics System Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global AI Imaging and Diagnostics System Sales Value Share by Application (2021-2026) Table 28. Global AI Imaging and Diagnostics System Sales Value Share by Application (2027-2032) Table 29. Global AI Imaging and Diagnostics System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global AI Imaging and Diagnostics System Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global AI Imaging and Diagnostics System Sales Value Share by Region (2021-2026) Table 32. Global AI Imaging and Diagnostics System Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global AI Imaging and Diagnostics System Sales Value Share by Region (2027-2032) Table 34. Global AI Imaging and Diagnostics System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global AI Imaging and Diagnostics System Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global AI Imaging and Diagnostics System Sales Value Market Share by Country (2021-2026) Table 37. Global AI Imaging and Diagnostics System Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global AI Imaging and Diagnostics System Sales Value Market Share by Country (2027-2032) Table 39. Siemens Healthineers AG Company Information Table 40. Siemens Healthineers AG Business Overview Table 41. Siemens Healthineers AG AI Imaging and Diagnostics System Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Siemens Healthineers AG AI Imaging and Diagnostics System Product Portfolio Table 43. Siemens Healthineers AG Recent Development Table 44. GE Healthcare Company Information Table 45. GE Healthcare Business Overview Table 46. GE Healthcare AI Imaging and Diagnostics System Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. GE Healthcare AI Imaging and Diagnostics System Product Portfolio Table 48. GE Healthcare Recent Development Table 49. IBM Watson Health Company Information Table 50. IBM Watson Health Business Overview Table 51. IBM Watson Health AI Imaging and Diagnostics System Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. IBM Watson Health AI Imaging and Diagnostics System Product Portfolio Table 53. IBM Watson Health Recent Development Table 54. Philips Healthcare Company Information Table 55. Philips Healthcare Business Overview Table 56. Philips Healthcare AI Imaging and Diagnostics System Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Philips Healthcare AI Imaging and Diagnostics System Product Portfolio Table 58. Philips Healthcare Recent Development Table 59. AliveCor Inc. Company Information Table 60. AliveCor Inc. Business Overview Table 61. AliveCor Inc. AI Imaging and Diagnostics System Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. AliveCor Inc. AI Imaging and Diagnostics System Product Portfolio Table 63. AliveCor Inc. Recent Development Table 64. Zebra Medical Vision, Inc. Company Information Table 65. Zebra Medical Vision, Inc. Business Overview Table 66. Zebra Medical Vision, Inc. AI Imaging and Diagnostics System Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Zebra Medical Vision, Inc. AI Imaging and Diagnostics System Product Portfolio Table 68. Zebra Medical Vision, Inc. Recent Development Table 69. Riverain Technologies Company Information Table 70. Riverain Technologies Business Overview Table 71. Riverain Technologies AI Imaging and Diagnostics System Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Riverain Technologies AI Imaging and Diagnostics System Product Portfolio Table 73. Riverain Technologies Recent Development Table 74. Vuno, Inc. Company Information Table 75. Vuno, Inc. Business Overview Table 76. Vuno, Inc. AI Imaging and Diagnostics System Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Vuno, Inc. AI Imaging and Diagnostics System Product Portfolio Table 78. Vuno, Inc. Recent Development Table 79. Aidoc Company Information Table 80. Aidoc Business Overview Table 81. Aidoc AI Imaging and Diagnostics System Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Aidoc AI Imaging and Diagnostics System Product Portfolio Table 83. Aidoc Recent Development Table 84. Neural Analytics Company Information Table 85. Neural Analytics Business Overview Table 86. Neural Analytics AI Imaging and Diagnostics System Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Neural Analytics AI Imaging and Diagnostics System Product Portfolio Table 88. Neural Analytics Recent Development Table 89. Imagen Technologies Company Information Table 90. Imagen Technologies Business Overview Table 91. Imagen Technologies AI Imaging and Diagnostics System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Imagen Technologies AI Imaging and Diagnostics System Product Portfolio Table 93. Imagen Technologies Recent Development Table 94. Digital Diagnostics, Inc. Company Information Table 95. Digital Diagnostics, Inc. Business Overview Table 96. Digital Diagnostics, Inc. AI Imaging and Diagnostics System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Digital Diagnostics, Inc. AI Imaging and Diagnostics System Product Portfolio Table 98. Digital Diagnostics, Inc. Recent Development Table 99. Google (Subsidiary of Alphabet, Inc.) Company Information Table 100. Google (Subsidiary of Alphabet, Inc.) Business Overview Table 101. Google (Subsidiary of Alphabet, Inc.) AI Imaging and Diagnostics System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Google (Subsidiary of Alphabet, Inc.) AI Imaging and Diagnostics System Product Portfolio Table 103. Google (Subsidiary of Alphabet, Inc.) Recent Development Table 104. Heartflow Company Information Table 105. Heartflow Business Overview Table 106. Heartflow AI Imaging and Diagnostics System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Heartflow AI Imaging and Diagnostics System Product Portfolio Table 108. Heartflow Recent Development Table 109. Digital Diagnostics (Formerly Known as Idx) Company Information Table 110. Digital Diagnostics (Formerly Known as Idx) Business Overview Table 111. Digital Diagnostics (Formerly Known as Idx) AI Imaging and Diagnostics System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Digital Diagnostics (Formerly Known as Idx) AI Imaging and Diagnostics System Product Portfolio Table 113. Digital Diagnostics (Formerly Known as Idx) Recent Development Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. AI Imaging and Diagnostics System Product Image Figure 2. Global AI Imaging and Diagnostics System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Imaging and Diagnostics System Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Imaging and Diagnostics System Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hardware Image Figure 8. Software Image Figure 9. Global AI Imaging and Diagnostics System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI Imaging and Diagnostics System Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI Imaging and Diagnostics System Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Diagnostic Centers Image Figure 14. Others Image Figure 15. Global AI Imaging and Diagnostics System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global AI Imaging and Diagnostics System Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global AI Imaging and Diagnostics System Sales Value Share by Application (2021-2032) Figure 18. Global AI Imaging and Diagnostics System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global AI Imaging and Diagnostics System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America AI Imaging and Diagnostics System Sales Value (2021-2032) & (US$ Million) Figure 21. North America AI Imaging and Diagnostics System Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe AI Imaging and Diagnostics System Sales Value (2021-2032) & (US$ Million) Figure 23. Europe AI Imaging and Diagnostics System Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific AI Imaging and Diagnostics System Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific AI Imaging and Diagnostics System Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America AI Imaging and Diagnostics System Sales Value (2021-2032) & (US$ Million) Figure 27. South America AI Imaging and Diagnostics System Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa AI Imaging and Diagnostics System Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa AI Imaging and Diagnostics System Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware
  • Software
Applications
  • Hospitals
  • Diagnostic Centers
  • Others
Companies covered
  • Siemens Healthineers AG
  • GE Healthcare
  • IBM Watson Health
  • Philips Healthcare
  • AliveCor Inc.
  • Zebra Medical Vision, Inc.
  • Riverain Technologies
  • Vuno, Inc.
  • Aidoc
  • Neural Analytics
  • Imagen Technologies
  • Digital Diagnostics, Inc.
  • Google (Subsidiary of Alphabet, Inc.)
  • Heartflow
  • Digital Diagnostics (Formerly Known as Idx)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Imaging and Diagnostics System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Imaging and Diagnostics System Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Imaging and Diagnostics System Market Dynamics
  1. 2.1 AI Imaging and Diagnostics System Industry Trends
  2. 2.2 AI Imaging and Diagnostics System Industry Drivers
  3. 2.3 AI Imaging and Diagnostics System Industry Opportunities and Challenges
  4. 2.4 AI Imaging and Diagnostics System Industry Restraints
3 AI Imaging and Diagnostics System Market by Company
  1. 3.1 Global AI Imaging and Diagnostics System Company Revenue Ranking in 2025
  2. 3.2 Global AI Imaging and Diagnostics System Revenue by Company (2021-2026)
  3. 3.3 Global AI Imaging and Diagnostics System Company Ranking (2024-2026)
  4. 3.4 Global AI Imaging and Diagnostics System Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Imaging and Diagnostics System Company Product Type and Application
  6. 3.6 Global AI Imaging and Diagnostics System Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Imaging and Diagnostics System Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Imaging and Diagnostics System Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Imaging and Diagnostics System Market by Type
  1. 4.1 AI Imaging and Diagnostics System Type Introduction
  2. 4.1.1 Hardware
  3. 4.1.2 Software
  4. 4.2 Global AI Imaging and Diagnostics System Sales Value by Type
  5. 4.2.1 Global AI Imaging and Diagnostics System Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI Imaging and Diagnostics System Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI Imaging and Diagnostics System Sales Value Share by Type (2021-2032)
5 AI Imaging and Diagnostics System Market by Application
  1. 5.1 AI Imaging and Diagnostics System Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Diagnostic Centers
  4. 5.1.3 Others
  5. 5.2 Global AI Imaging and Diagnostics System Sales Value by Application
  6. 5.2.1 Global AI Imaging and Diagnostics System Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global AI Imaging and Diagnostics System Sales Value by Application (2021-2032)
  8. 5.2.3 Global AI Imaging and Diagnostics System Sales Value Share by Application (2021-2032)
6 AI Imaging and Diagnostics System Regional Value Analysis
  1. 6.1 Global AI Imaging and Diagnostics System Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Imaging and Diagnostics System Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Imaging and Diagnostics System Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Imaging and Diagnostics System Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Imaging and Diagnostics System Sales Value (2021-2032)
  7. 6.3.2 North America AI Imaging and Diagnostics System Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Imaging and Diagnostics System Sales Value (2021-2032)
  10. 6.4.2 Europe AI Imaging and Diagnostics System Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Imaging and Diagnostics System Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Imaging and Diagnostics System Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Imaging and Diagnostics System Sales Value (2021-2032)
  16. 6.6.2 South America AI Imaging and Diagnostics System Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Imaging and Diagnostics System Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Imaging and Diagnostics System Sales Value Share by Country, 2025 VS 2032
7 AI Imaging and Diagnostics System Country-level Value Analysis
  1. 7.1 Global AI Imaging and Diagnostics System Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Imaging and Diagnostics System Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Imaging and Diagnostics System Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Imaging and Diagnostics System Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Imaging and Diagnostics System Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Imaging and Diagnostics System Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Imaging and Diagnostics System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Siemens Healthineers AG
  2. 8.1.1 Siemens Healthineers AG Company Information
  3. 8.1.2 Siemens Healthineers AG Business Overview
  4. 8.1.3 Siemens Healthineers AG AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Siemens Healthineers AG AI Imaging and Diagnostics System Product Portfolio
  6. 8.1.5 Siemens Healthineers AG Recent Developments
  7. 8.2 GE Healthcare
  8. 8.2.1 GE Healthcare Company Information
  9. 8.2.2 GE Healthcare Business Overview
  10. 8.2.3 GE Healthcare AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GE Healthcare AI Imaging and Diagnostics System Product Portfolio
  12. 8.2.5 GE Healthcare Recent Developments
  13. 8.3 IBM Watson Health
  14. 8.3.1 IBM Watson Health Company Information
  15. 8.3.2 IBM Watson Health Business Overview
  16. 8.3.3 IBM Watson Health AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  17. 8.3.4 IBM Watson Health AI Imaging and Diagnostics System Product Portfolio
  18. 8.3.5 IBM Watson Health Recent Developments
  19. 8.4 Philips Healthcare
  20. 8.4.1 Philips Healthcare Company Information
  21. 8.4.2 Philips Healthcare Business Overview
  22. 8.4.3 Philips Healthcare AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Philips Healthcare AI Imaging and Diagnostics System Product Portfolio
  24. 8.4.5 Philips Healthcare Recent Developments
  25. 8.5 AliveCor Inc.
  26. 8.5.1 AliveCor Inc. Company Information
  27. 8.5.2 AliveCor Inc. Business Overview
  28. 8.5.3 AliveCor Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AliveCor Inc. AI Imaging and Diagnostics System Product Portfolio
  30. 8.5.5 AliveCor Inc. Recent Developments
  31. 8.6 Zebra Medical Vision, Inc.
  32. 8.6.1 Zebra Medical Vision, Inc. Company Information
  33. 8.6.2 Zebra Medical Vision, Inc. Business Overview
  34. 8.6.3 Zebra Medical Vision, Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zebra Medical Vision, Inc. AI Imaging and Diagnostics System Product Portfolio
  36. 8.6.5 Zebra Medical Vision, Inc. Recent Developments
  37. 8.7 Riverain Technologies
  38. 8.7.1 Riverain Technologies Company Information
  39. 8.7.2 Riverain Technologies Business Overview
  40. 8.7.3 Riverain Technologies AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Riverain Technologies AI Imaging and Diagnostics System Product Portfolio
  42. 8.7.5 Riverain Technologies Recent Developments
  43. 8.8 Vuno, Inc.
  44. 8.8.1 Vuno, Inc. Company Information
  45. 8.8.2 Vuno, Inc. Business Overview
  46. 8.8.3 Vuno, Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vuno, Inc. AI Imaging and Diagnostics System Product Portfolio
  48. 8.8.5 Vuno, Inc. Recent Developments
  49. 8.9 Aidoc
  50. 8.9.1 Aidoc Company Information
  51. 8.9.2 Aidoc Business Overview
  52. 8.9.3 Aidoc AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Aidoc AI Imaging and Diagnostics System Product Portfolio
  54. 8.9.5 Aidoc Recent Developments
  55. 8.10 Neural Analytics
  56. 8.10.1 Neural Analytics Company Information
  57. 8.10.2 Neural Analytics Business Overview
  58. 8.10.3 Neural Analytics AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Neural Analytics AI Imaging and Diagnostics System Product Portfolio
  60. 8.10.5 Neural Analytics Recent Developments
  61. 8.11 Imagen Technologies
  62. 8.11.1 Imagen Technologies Company Information
  63. 8.11.2 Imagen Technologies Business Overview
  64. 8.11.3 Imagen Technologies AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Imagen Technologies AI Imaging and Diagnostics System Product Portfolio
  66. 8.11.5 Imagen Technologies Recent Developments
  67. 8.12 Digital Diagnostics, Inc.
  68. 8.12.1 Digital Diagnostics, Inc. Company Information
  69. 8.12.2 Digital Diagnostics, Inc. Business Overview
  70. 8.12.3 Digital Diagnostics, Inc. AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Digital Diagnostics, Inc. AI Imaging and Diagnostics System Product Portfolio
  72. 8.12.5 Digital Diagnostics, Inc. Recent Developments
  73. 8.13 Google (Subsidiary of Alphabet, Inc.)
  74. 8.13.1 Google (Subsidiary of Alphabet, Inc.) Company Information
  75. 8.13.2 Google (Subsidiary of Alphabet, Inc.) Business Overview
  76. 8.13.3 Google (Subsidiary of Alphabet, Inc.) AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Google (Subsidiary of Alphabet, Inc.) AI Imaging and Diagnostics System Product Portfolio
  78. 8.13.5 Google (Subsidiary of Alphabet, Inc.) Recent Developments
  79. 8.14 Heartflow
  80. 8.14.1 Heartflow Company Information
  81. 8.14.2 Heartflow Business Overview
  82. 8.14.3 Heartflow AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Heartflow AI Imaging and Diagnostics System Product Portfolio
  84. 8.14.5 Heartflow Recent Developments
  85. 8.15 Digital Diagnostics (Formerly Known as Idx)
  86. 8.15.1 Digital Diagnostics (Formerly Known as Idx) Company Information
  87. 8.15.2 Digital Diagnostics (Formerly Known as Idx) Business Overview
  88. 8.15.3 Digital Diagnostics (Formerly Known as Idx) AI Imaging and Diagnostics System Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Digital Diagnostics (Formerly Known as Idx) AI Imaging and Diagnostics System Product Portfolio
  90. 8.15.5 Digital Diagnostics (Formerly Known as Idx) Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst